Higher levels of HDL cholesterol are associated with a decreased likelihood of albuminuria in patients with long-standing standing type 1 diabetes

被引:39
作者
Molitch, ME
Rupp, D
Carnethon, M
机构
[1] Northwestern Univ, Div Endocrinol Metab & Mol Med, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA
[2] Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA
关键词
D O I
10.2337/diacare.29.01.06.dc05-1583
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - The objective of this study was to determine whether high levels of HDL cholesterol are associated with a lower prevalence of albuminuria. RESEARCH DESIGN AND METHODS - We analyzed the lipid profiles of patients with type I diabetes of >= 20 years duration in 42 patients With albuminuria (28 microalbuminuria and 14 macroalbuminuria) and 65 patients without increased albumin excretion before any interventions with either statins or ACE inhibitors. RESULTS - Several characteristics were similar in the two groups: sex, age, duration of diabetes, total cholesterol, LDL cholesterol, and triglycerides. By univariate analysis, significant differences (P < 0.01) were found in HDL cholesterol (albuminuria 1.42 mg/dl, no albuminuria 1.71 mg/dl, P < 0.01), HbA(1c) (AlC) (albuminuria 8.5%, no albuminuria 7.5%), and proportions with no, background, and proliferative retinopathy (albuminuria 2.4, 16.7, and 81%; no albuminuria 24.6, 52.3, and 23.1%, respectively). When adjusted for age and sex, a 0.26-mmol/l (10-mg/dl) increase in HDL cholesterol is associated with an odds ratio (OR) of 0.70 (95% CI 0.54-0.90) for having albuminuria. In a multivariate model that adjusted for age, sex, diabetes duration, and AlC, for every 0.54-mmol/l (21-mg/dl) increase in HDL cholesterol, patients are approximately half (OR 0.51 [95% CI 0.30-0.86]) as likely to have albuminuria, even after controlling or AlC. CONCLUSIONS - Higher HDL cholesterol levels may be protective against the development of albuminuria in patients with type I diabetes. Whether this is due to the HDL cholesterol levels or whether they serve as a marker for some other mechanism remains to be determined.
引用
收藏
页码:78 / 82
页数:5
相关论文
共 44 条
  • [1] Characteristics of Type 1 diabetes of over 50 years duration (the Golden Years Cohort)
    Bain, SC
    Gill, GV
    Dyer, PH
    Jones, AF
    Murphy, M
    Jones, KE
    Smyth, C
    Barnett, AH
    [J]. DIABETIC MEDICINE, 2003, 20 (10) : 808 - 811
  • [2] THE EFFECT OF PROTEINURIA ON RELATIVE MORTALITY IN TYPE-1 (INSULIN-DEPENDENT) DIABETES-MELLITUS
    BORCHJOHNSEN, K
    ANDERSEN, PK
    DECKERT, T
    [J]. DIABETOLOGIA, 1985, 28 (08) : 590 - 596
  • [3] Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy
    Breyer, JA
    Bain, RP
    Evans, JK
    Nahman, NS
    Lewis, EJ
    Cooper, M
    McGill, J
    Berl, T
    Rohde, R
    Hunsicker, LG
    Lachin, J
    Greenhouse, SW
    Verme, DA
    Turlington, TR
    Burrows, PK
    Wish, J
    Sheehan, J
    Pohl, M
    Berl, T
    Santiago, G
    Hunsicker, L
    Kern, EFO
    Lemann, J
    Blementhal, S
    Bresnahan, BS
    Hebert, L
    Goldfarb, S
    Kobrin, S
    Rodby, R
    Levey, A
    McLaughlin, M
    Williams, M
    McGill, J
    Whittler, F
    Rutecki, G
    Cattran, D
    Lietz, S
    Valaitis, D
    Hano, J
    Maxwell, D
    Porush, J
    Spitalewitz, S
    Shapiro, K
    Adler, S
    Tolchin, N
    Hoy, W
    Bernstein, R
    Svetkey, L
    Sharon, Z
    Rausenbaum, B
    [J]. KIDNEY INTERNATIONAL, 1996, 50 (05) : 1651 - 1658
  • [4] Factors associated with microalbuminuria in Type 1 diabetes mellitus:: a cross-sectional study
    Campos-Pastor, MM
    Escobar-Jiménez, F
    Mezquita, P
    Herrera-Pombo, JL
    Hawkins-Carranza, F
    Luna, JD
    Azriel, S
    Serraclara, A
    Rigopoulos, M
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2000, 48 (01) : 43 - 49
  • [5] The need for early predictors of diabetic nephropathy risk - Is albumin excretion rate sufficient?
    Caramori, ML
    Fioretto, P
    Mauer, M
    [J]. DIABETES, 2000, 49 (09) : 1399 - 1408
  • [6] Differing associations of lipid and lipoprotein disturbances with the macrovascular and microvascular complications of type 1 diabetes
    Chaturvedi, N
    Fuller, JH
    Taskinen, MR
    [J]. DIABETES CARE, 2001, 24 (12) : 2071 - 2077
  • [7] Genetic determinants of diabetic nephropathy
    Chowdhury, TA
    Dyer, PH
    Kumar, S
    Barnett, AH
    Bain, SC
    [J]. CLINICAL SCIENCE, 1999, 96 (03) : 221 - 230
  • [8] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
    Cleeman, JI
    Grundy, SM
    Becker, D
    Clark, LT
    Cooper, RS
    Denke, MA
    Howard, WJ
    Hunninghake, DB
    Illingworth, DR
    Luepker, RV
    McBride, P
    McKenney, JM
    Pasternak, RC
    Stone, NJ
    Van Horn, L
    Brewer, HB
    Ernst, ND
    Gordon, D
    Levy, D
    Rifkind, B
    Rossouw, JE
    Savage, P
    Haffner, SM
    Orloff, DG
    Proschan, MA
    Schwartz, JS
    Sempos, CT
    Shero, ST
    Murray, EZ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19): : 2486 - 2497
  • [9] Risk factors for renal replacement therapy in the Early Treatment Diabetic Retinopathy Study (ETDRS), Early Treatment Diabetic Retinopathy Study Report No. 26
    Cusick, M
    Chew, EY
    Hoogwerf, B
    Agrón, E
    Wu, L
    Lindley, A
    Ferris, FL
    [J]. KIDNEY INTERNATIONAL, 2004, 66 (03) : 1173 - 1179
  • [10] Diabet Control Complications DCCT Res Grp, 1995, KIDNEY INT, V47, P1703